查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1689639

局部止血劑市場：全球產業分析、市場規模、佔有率、成長、趨勢與未來預測（2025-2032）

Topical Hemostat Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 250 Pages | 商品交期: 2-5個工作天內

價格
簡介目錄

Persistence Market Research 最近發布了一份關於全球局部止血劑市場的綜合報告。該報告對市場促進因素、趨勢、機會、促進因素和挑戰等關鍵市場動態進行了全面評估，並對市場結構提供了詳細的見解。本研究報告採用獨家資料和統計數據，概述了 2025 年至 2032 年全球局部止血劑市場的預期成長軌跡。

關鍵見解

  • 局部止血劑市場規模（2025年）：61億美元
  • 市場規模預測（以金額為準，2032年）：113.6億美元
  • 全球市場成長率（2025-2032年複合年成長率）：9.3%

局部止血劑市場：分析範圍

局部止血劑在外科手術和創傷護理中發揮重要作用，有助於在醫療過程中快速控制出血。這些止血劑廣泛應用於醫院、門診手術中心和專科診所，為小型到大型手術提供有效的解決方案。該市場包括多種局部止血劑，包括可吸收明膠海綿、氧化再生纖維素、基於膠原蛋白的止血劑和基於凝血酶的產品。微創手術的採用率上升、全球手術數量的增加以及止血技術的進步是推動市場成長的主要因素。

市場成長動力：

全球局部止血劑市場受到外科手術數量的增加、需要頻繁醫療干預的老齡化人口以及心血管疾病和癌症等慢性疾病患病率上升的推動。此外，微創和機器人輔助手術的日益普及也推動了對有效止血解決方案的需求。技術進步，例如開發具有更好生物相容性和更快作用特性的先進止血劑，也在推動市場擴張。此外，醫療保健專業人士越來越意識到局部止血劑優於傳統縫合方法，這也促進了市場擴張。

市場限制：

儘管市場成長潛力很大，但局部止血劑市場面臨嚴格的監管核准、產品成本上升以及某些地區報銷有限等挑戰。管理止血產品開發和商業化的嚴格法律規範給製造商帶來了合規挑戰。此外，先進的止血劑相對昂貴，這可能會阻礙其在成本敏感的市場（尤其是新興經濟體）中的應用。一些醫療保健系統對某些局部止血劑的報銷有限，進一步限制了市場滲透。

市場機會：

由於產品不斷創新、在各個外科專業的應用範圍不斷擴大以及在門診醫療環境中的應用日益廣泛，局部止血劑市場提供了巨大的成長機會。生物分解性和生物活性止血劑與基於奈米技術的解決方案的結合有望提高產品的有效性並擴大市場範圍。重症監護和軍事醫療應用對照護現場止血解決方案的需求不斷成長也將為市場擴張開闢新的途徑。策略合作、研發投資以及開發具成本效益的止血解決方案將是利用新市場機會的關鍵。

本報告回答的關鍵問題

  • 推動全球局部止血劑市場成長的關鍵因素有哪些？
  • 醫療保健場景中採用最廣泛的產品類型和應用有哪些？
  • 技術進步如何影響局部止血劑市場的競爭格局？
  • 誰是塑造市場的關鍵參與者？他們採取什麼策略來維持成長？
  • 全球局部止血劑市場有哪些新興趨勢與前景？

目錄

第1章執行摘要

第2章 市場概述

  • 市場範圍和定義
  • 價值鏈分析
  • 宏觀經濟因素
    • 世界GDP展望
    • 全球各地區紡織品種類
    • 全球服飾需求（按地區）
    • 全球針織機銷售概況
  • 預測因子－相關性和影響力
  • COVID-19影響評估
  • PESTLE分析
  • 波特五力分析
  • 地緣政治緊張局勢：市場影響
  • 監管和技術格局

第3章 市場動態

  • 驅動程式
  • 限制因素
  • 機會
  • 趨勢

第4章 價格趨勢分析（2019-2032）

  • 區域價格分析
  • 按細分市場定價
  • 價格影響因素

5. 全球局部止血劑市場展望

  • 主要亮點
  • 全球局部止血劑市場展望（按類型）
    • 簡介/主要發現
    • 按類型分類的歷史市場規模分析（價值（十億美元）和數量，2019-2024 年）
    • 當前市場規模分析及按類型預測（價值（十億美元）和數量，2025-2032）
      • 纖維蛋白
      • 凝血酶
      • 纖維素
      • 膠原蛋白
      • 明膠
      • 膠水
    • 市場吸引力分析：按類型
  • 全球局部止血劑市場應用展望
    • 簡介/主要發現
    • 按應用分類的歷史市場規模分析（價值（十億美元）和數量，2019-2024 年）
    • 目前市場規模分析及應用預測（價值（十億美元）和數量，2025-2032）
      • 一般外科
      • 神經外科
      • 血管外科
      • 心血管外科
    • 市場吸引力分析：按應用
  • 全球局部止血劑市場展望（依最終用途）
    • 簡介/主要發現
    • 按最終用途分類的歷史市場規模分析（價值（十億美元）和數量，2019-2024 年）
    • 目前市場規模分析及依最終用途預測（價值（十億美元）及數量，2025-2032）
      • 醫院
      • 門診手術中心

6. 全球局部止血劑市場（按地區）展望

  • 主要亮點
  • 按地區分類的歷史市場規模分析（價值（十億美元）和數量，2019-2024 年）
  • 目前市場規模分析及各地區預測（價值（十億美元）及數量，2025-2032）
    • 北美洲
    • 歐洲
    • 東亞
    • 南亞和大洋洲
    • 拉丁美洲
    • 中東和非洲
  • 市場吸引力分析：按地區

7. 北美局部止血劑市場展望

8. 歐洲局部止血劑市場展望

9. 東亞局部止血劑市場展望

10. 南亞和大洋洲局部止血劑市場展望

第 11 章拉丁美洲局部止血劑市場展望

12.中東和非洲局部止血劑市場展望

第13章競爭格局

  • 市場佔有率分析（2025年）
  • 市場結構
    • 競賽實力圖譜
    • 競爭儀錶板
  • 公司簡介
    • BD
    • Baxter
    • Pfizer Inc.
    • Medicom
    • HemoSonics
    • Hemostasis, LLC
    • Medline Industries
    • Johnson &Johnson
    • Integra LifeSciences
    • Teleflex Incorporated
    • HemCon Medical Technologies Inc.

第14章 附錄

  • 調查方法
  • 調查前提
  • 首字母縮寫和簡稱
簡介目錄
Product Code: PMRREP35166

Persistence Market Research has recently released a comprehensive report on the worldwide market for topical hemostats. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global topical hemostat market from 2025 to 2032.

Key Insights:

  • Topical Hemostat Market Size (2025E): US$ 6.10 Bn
  • Projected Market Value (2032F): US$ 11.36 Bn
  • Global Market Growth Rate (CAGR 2025 to 2032): 9.3%

Topical Hemostat Market - Report Scope:

Topical hemostats play a crucial role in surgical and trauma care, aiding in the rapid control of bleeding during medical procedures. These hemostatic agents are widely used in hospitals, ambulatory surgical centers, and specialty clinics, providing effective solutions for both minor and major surgical interventions. The market encompasses a diverse range of topical hemostats, including absorbable gelatin sponges, oxidized regenerated cellulose, collagen-based hemostats, and thrombin-based products. The growing adoption of minimally invasive surgeries, an increasing number of surgical procedures worldwide, and advancements in hemostatic technologies are key factors propelling market growth.

Market Growth Drivers:

The global topical hemostat market is driven by the rising number of surgical procedures, an aging population requiring frequent medical interventions, and the increasing prevalence of chronic conditions such as cardiovascular diseases and cancer. The demand for effective bleeding control solutions is also bolstered by the growing adoption of minimally invasive and robotic-assisted surgeries. Technological advancements, such as the development of advanced hemostatic agents with enhanced biocompatibility and rapid action, further support market expansion. Additionally, increased awareness among healthcare professionals about the benefits of topical hemostats over traditional suturing methods contributes to market growth.

Market Restraints:

Despite strong growth potential, the topical hemostat market faces challenges related to stringent regulatory approvals, high product costs, and reimbursement limitations in certain regions. Stringent regulatory frameworks governing the development and commercialization of hemostatic products pose compliance challenges for manufacturers. Additionally, the relatively high cost of advanced hemostatic agents may hinder their adoption in cost-sensitive markets, particularly in emerging economies. Limited reimbursement coverage for certain topical hemostats in some healthcare systems further restricts market penetration.

Market Opportunities:

The topical hemostat market presents significant growth opportunities driven by continuous product innovation, expanding applications in various surgical specialties, and increasing adoption in ambulatory care settings. The integration of biodegradable and bioactive hemostats, along with nanotechnology-based solutions, is expected to enhance product effectiveness and expand market scope. The rising demand for point-of-care hemostatic solutions in emergency and military medical applications also creates new avenues for market expansion. Strategic collaborations, investments in R&D, and the development of cost-effective hemostatic solutions will be key to capitalizing on emerging market opportunities.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the topical hemostat market globally?
  • Which product types and applications are witnessing the highest adoption across different healthcare settings?
  • How are technological advancements influencing the competitive landscape of the topical hemostat market?
  • Who are the key players shaping the market, and what strategies are they employing to sustain growth?
  • What are the emerging trends and future prospects in the global topical hemostat market?

Competitive Intelligence and Business Strategy:

Leading players in the global topical hemostat market, including Baxter International Inc., Johnson & Johnson, B. Braun Melsungen AG, and Medtronic plc, focus on innovation, product differentiation, and strategic partnerships to strengthen their market presence. These companies invest in R&D to develop advanced hemostatic solutions, including fibrin sealants, bioabsorbable agents, and combination hemostatic technologies catering to diverse surgical needs. Collaborations with hospitals, surgical centers, and distributors facilitate market expansion and drive product adoption. Additionally, companies emphasize clinical research and physician education to enhance market acceptance and improve surgical outcomes.

Key Companies Profiled:

  • Baxter International Inc.
  • Johnson & Johnson
  • B. Braun Melsungen AG
  • Medtronic plc
  • Pfizer Inc.
  • Integra LifeSciences Holdings Corporation
  • Stryker Corporation
  • Teleflex Incorporated
  • CryoLife, Inc.
  • Biom'Up SAS

Topical Hemostat Market Segmentation

By Type

  • Fibrin
  • Thrombin
  • Cellulose
  • Collagen
  • Gelatin
  • Adhesives

By Application

  • General Surgery
  • Neurosurgery
  • Vascular Surgery
  • Cardiovascular Surgery

By End Use

  • Hospitals
  • Ambulatory Surgical Centers

By Region

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Middle East and Africa
  • Latin America

Table of Contents

1. Executive Summary

  • 1.1. Global Topical Hemostat Market Snapshot 2025-2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Bn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global Textile Typeion by Region
    • 2.3.3. Global Cloths Demand by Region
    • 2.3.4. Global Knitting Machine Sales Overview
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Topical Hemostat Market Outlook:

  • 5.1. Key Highlights
  • 5.2. Global Topical Hemostat Market Outlook: Type
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Type, 2019-2024
    • 5.2.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
      • 5.2.3.1. Fibrin
      • 5.2.3.2. Thrombin
      • 5.2.3.3. Cellulose
      • 5.2.3.4. Collagen
      • 5.2.3.5. Gelatin
      • 5.2.3.6. Adhesives
    • 5.2.4. Market Attractiveness Analysis: Type
  • 5.3. Global Topical Hemostat Market Outlook: Application
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Application, 2019-2024
    • 5.3.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
      • 5.3.3.1. General Surgery
      • 5.3.3.2. Neurosurgery
      • 5.3.3.3. Vascular Surgery
      • 5.3.3.4. Cardiovascular Surgery
    • 5.3.4. Market Attractiveness Analysis: Application
  • 5.4. Global Topical Hemostat Market Outlook: End Use
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by End Use, 2019-2024
    • 5.4.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
      • 5.4.3.1. Hospitals
      • 5.4.3.2. Ambulatory Surgical Centers

6. Global Topical Hemostat Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Topical Hemostat Market Outlook:

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 7.4.1. Fibrin
    • 7.4.2. Thrombin
    • 7.4.3. Cellulose
    • 7.4.4. Collagen
    • 7.4.5. Gelatin
    • 7.4.6. Adhesives
  • 7.5. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 7.5.1. General Surgery
    • 7.5.2. Neurosurgery
    • 7.5.3. Vascular Surgery
    • 7.5.4. Cardiovascular Surgery
  • 7.6. North America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Ambulatory Surgical Centers

8. Europe Topical Hemostat Market Outlook:

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 8.4.1. Fibrin
    • 8.4.2. Thrombin
    • 8.4.3. Cellulose
    • 8.4.4. Collagen
    • 8.4.5. Gelatin
    • 8.4.6. Adhesives
  • 8.5. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 8.5.1. General Surgery
    • 8.5.2. Neurosurgery
    • 8.5.3. Vascular Surgery
    • 8.5.4. Cardiovascular Surgery
  • 8.6. Europe Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Ambulatory Surgical Centers

9. East Asia Topical Hemostat Market Outlook:

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 9.4.1. Fibrin
    • 9.4.2. Thrombin
    • 9.4.3. Cellulose
    • 9.4.4. Collagen
    • 9.4.5. Gelatin
    • 9.4.6. Adhesives
  • 9.5. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 9.5.1. General Surgery
    • 9.5.2. Neurosurgery
    • 9.5.3. Vascular Surgery
    • 9.5.4. Cardiovascular Surgery
  • 9.6. East Asia Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Ambulatory Surgical Centers

10. South Asia & Oceania Topical Hemostat Market Outlook:

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 10.4.1. Fibrin
    • 10.4.2. Thrombin
    • 10.4.3. Cellulose
    • 10.4.4. Collagen
    • 10.4.5. Gelatin
    • 10.4.6. Adhesives
  • 10.5. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 10.5.1. General Surgery
    • 10.5.2. Neurosurgery
    • 10.5.3. Vascular Surgery
    • 10.5.4. Cardiovascular Surgery
  • 10.6. South Asia & Oceania Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Ambulatory Surgical Centers

11. Latin America Topical Hemostat Market Outlook:

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 11.4.1. Fibrin
    • 11.4.2. Thrombin
    • 11.4.3. Cellulose
    • 11.4.4. Collagen
    • 11.4.5. Gelatin
    • 11.4.6. Adhesives
  • 11.5. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 11.5.1. General Surgery
    • 11.5.2. Neurosurgery
    • 11.5.3. Vascular Surgery
    • 11.5.4. Cardiovascular Surgery
  • 11.6. Latin America Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Ambulatory Surgical Centers

12. Middle East & Africa Topical Hemostat Market Outlook:

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Type, 2025-2032
    • 12.4.1. Fibrin
    • 12.4.2. Thrombin
    • 12.4.3. Cellulose
    • 12.4.4. Collagen
    • 12.4.5. Gelatin
    • 12.4.6. Adhesives
  • 12.5. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by Application, 2025-2032
    • 12.5.1. General Surgery
    • 12.5.2. Neurosurgery
    • 12.5.3. Vascular Surgery
    • 12.5.4. Cardiovascular Surgery
  • 12.6. Middle East & Africa Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, by End Use, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Ambulatory Surgical Centers

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. BD
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Type Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Baxter
    • 13.3.3. Pfizer Inc.
    • 13.3.4. Medicom
    • 13.3.5. HemoSonics
    • 13.3.6. Hemostasis, LLC
    • 13.3.7. Medline Industries
    • 13.3.8. Johnson & Johnson
    • 13.3.9. Integra LifeSciences
    • 13.3.10. Teleflex Incorporated
    • 13.3.11. HemCon Medical Technologies Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations